InVivoMAb anti-Dengue virus type 4 E protein DIII
BE0437
ApplicationsFlow Cytometry, Western Blot, ELISA, Neutralisation/Blocking
Product group Antibodies
ReactivityVirus
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-Dengue virus type 4 E protein DIII
- Delivery Days Customer7
- ApplicationsFlow Cytometry, Western Blot, ELISA, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDDV4-E88
- Concentration4-11 mg/ml
- Estimated Purity≥95% , Determined by SDS-PAGE
- HostMouse
- IsotypeIgG2c
- ReactivityVirus
- Storage Instruction2°C to 8°C
- UNSPSC41116161
References
- Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunity.Read this paper
- Recombinant Dengue Virus 4 Envelope Glycoprotein Virus-Like Particles Derived from Pichia pastoris are Capable of Eliciting Homotypic Domain III-Directed Neutralizing Antibodies.Read this paper
- A new quaternary structure epitope on dengue virus serotype 2 is the target of durable type-specific neutralizing antibodies.Read this paper
- Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection.Read this paper
